Cargando…
Neuropsychiatric Disorders in Chronic Kidney Disease
Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707423/ https://www.ncbi.nlm.nih.gov/pubmed/31474869 http://dx.doi.org/10.3389/fphar.2019.00932 |
_version_ | 1783445857902788608 |
---|---|
author | Simões e Silva, Ana Cristina Miranda, Aline Silva Rocha, Natalia Pessoa Teixeira, Antônio Lúcio |
author_facet | Simões e Silva, Ana Cristina Miranda, Aline Silva Rocha, Natalia Pessoa Teixeira, Antônio Lúcio |
author_sort | Simões e Silva, Ana Cristina |
collection | PubMed |
description | Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression. |
format | Online Article Text |
id | pubmed-6707423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67074232019-08-30 Neuropsychiatric Disorders in Chronic Kidney Disease Simões e Silva, Ana Cristina Miranda, Aline Silva Rocha, Natalia Pessoa Teixeira, Antônio Lúcio Front Pharmacol Pharmacology Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression. Frontiers Media S.A. 2019-08-16 /pmc/articles/PMC6707423/ /pubmed/31474869 http://dx.doi.org/10.3389/fphar.2019.00932 Text en Copyright © 2019 Simões e Silva, Miranda, Rocha and Teixeira http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Simões e Silva, Ana Cristina Miranda, Aline Silva Rocha, Natalia Pessoa Teixeira, Antônio Lúcio Neuropsychiatric Disorders in Chronic Kidney Disease |
title | Neuropsychiatric Disorders in Chronic Kidney Disease |
title_full | Neuropsychiatric Disorders in Chronic Kidney Disease |
title_fullStr | Neuropsychiatric Disorders in Chronic Kidney Disease |
title_full_unstemmed | Neuropsychiatric Disorders in Chronic Kidney Disease |
title_short | Neuropsychiatric Disorders in Chronic Kidney Disease |
title_sort | neuropsychiatric disorders in chronic kidney disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707423/ https://www.ncbi.nlm.nih.gov/pubmed/31474869 http://dx.doi.org/10.3389/fphar.2019.00932 |
work_keys_str_mv | AT simoesesilvaanacristina neuropsychiatricdisordersinchronickidneydisease AT mirandaalinesilva neuropsychiatricdisordersinchronickidneydisease AT rochanataliapessoa neuropsychiatricdisordersinchronickidneydisease AT teixeiraantoniolucio neuropsychiatricdisordersinchronickidneydisease |